Previously used VIV were used because there was no alternative. Either the patients die or you put a less than optimal valve in. With the arrival of DuAVR, clearly the 2 cardiologist in Canada disagree with your view that there is an alternative.
Expression the same opinion over and over does not necessarily make it right. I would back the views of the two canadian cardiologist anytime over yours with repect.
Ann: Exceptional Results in Second Valve-in-Valve Case, page-17
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$11.93 |
Change
-0.290(2.37%) |
Mkt cap ! $252.1M | |||
| Open | High | Low | Value | Volume |
| $12.20 | $12.22 | $11.21 | $199.1K | 17.01K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 577 | $11.59 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $11.93 | 131 | 1 |
View Market Depth
| Last trade - 16.10pm 21/10/2024 (20 minute delay) ? |
| AVR (ASX) Chart |